|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation of property and equipment | |||||
| Amortization of platform development and intangible assets | |||||
| Amortization of debt costs | |||||
| Noncash and accrued interest | |||||
| Loss on impairment of assets | |||||
| Loss on sale of assets | |||||
| Change in fair value of contingent consideration | |||||
| Liquidated damages | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Bad debt expense | |||||
| Provision for credit losses | |||||
| Non-cash lease expense | |||||
| Other, net | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Subscription acquisition costs | |||||
| Prepayments and other current assets | |||||
| Other long-term assets | |||||
| Accounts payable | |||||
| Accrued expenses and other | |||||
| Unearned revenue | |||||
| Subscription refund liability | |||||
| Subscription and returns reserve liability | |||||
| Operating lease liability | |||||
| Contingent consideration | |||||
| Other long-term liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of assets | |||||
| Payments for acquisitions, net of cash | |||||
| Purchases of intangible assets | |||||
| Capitalized platform development | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from bridge notes, net of debt costs | |||||
| Payment of Fexy put option | |||||
| Repayments under line of credit | |||||
| Proceeds from common stock private placement | |||||
| Repayment of Term Debt | |||||
| Proceeds from Simplify loan | |||||
| Proceeds from common stock public offering, net of offering costs | |||||
| Payments of issuance costs from common stock public offering | |||||
| Payments of debt issuance costs | |||||
| Payment of deferred cash payment | |||||
| Repayment of Simplify loan | |||||
| Payments of deferred cash payment | |||||
| Payments of taxes from common stock withheld | |||||
| Net cash (used in) provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents — beginning of year | |||||
| Cash and cash equivalents — end of period | |||||
| Cash and cash equivalents | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Noncash investing and financing activities | |||||
| Reclassification of stock-based compensation to platform development | |||||
| Purchase of intangible asset with accrued expenses and other | |||||
| Repurchase of common stock for Fexy put option | |||||
| Issuance of common stock upon exercise of stock options | |||||
| Issuance of common stock upon conversion of convertible preferred stock | |||||
| Series G Redeemable and Convertible Preferred Stock | |||||
| Series H convertible preferred stock | |||||
| Total issuance of common stock upon conversion of convertible preferred stock | |||||
| Issuance of common stock in connection with settlement of liquidated damages | |||||
| Issuance of common stock upon conversion of series H preferred stock | |||||
| Issuance of common stock in connection with an acquisition | |||||
| Deferred cash payments recorded in connection with acquisitions | |||||
| Assumption of liabilities in connection with acquisitions | |||||
| Reclassification to liability upon common stock modification | |||||
Loading...